July 13 Quick Takes: Spudich, Rutter to lead start-up Kainomyx; plus deals for Ovid-Angelini, Dewpoint-Merck and Kiadis-Sanofi

Spudich, Rutter to lead start-up focused on parasitic diseases
Kainomyx Inc. emerged from stealth Monday to discover and develop small molecules to treat malaria and other parasitic diseases. Co-founded in September by President and

Read the full 338 word article

How to gain access

Continue reading with a
two-week free trial.